UTSA immunologist selected by peers as fellow of national association
(Nov. 25, 2014) -- Bernard Arulanandam, UTSA Jane and Roland Blumberg Professor in Biology and assistant vice president for research support, has been named a fellow of the American Association for the Advancement of Science (AAAS). Arulanandam was elected by his peers for the honor, recognizing his scientific and socially distinguished efforts to advance science and its applications.
Arulanandam will receive the honor on Saturday, Feb. 14 at the 2015 annual meeting of the American Association for the Advancement of Science in San Jose, Calif.
"I want to congratulate Bernard on this well-deserved distinction. He joins a growing number of AAAS fellows here at UTSA, working in such diverse fields as anthropology, biomedical engineering, chemistry, cybersecurity, electrical engineering, physics and more," said John Frederick, UTSA provost and vice president for academic affairs. "Bernard's selection as an AAAS fellow is further testament to our outstanding faculty."
Arulanandam joined the UTSA faculty in 2001 and conducts research on bacterial infections and the body's immune response to infectious diseases. His goal is to develop vaccines and therapies for prevention and treatment. Much of his work centers on studying mucosal surfaces, which are significant entry points for pathogens and often serve as the body's first line of defense.
In the laboratory, Arulanandam studies Franciscella tularensis, a biothreat agent and the bacterium that causes the respiratory infection tularemia or rabbit fever. He is also working on developing a vaccine against Chlamydia trachomatis, the major global cause of bacterial sexually transmitted disease.
In 2009, Arulanandam and his UT Health Science Center colleague Guangming Zhong established an exclusive license and sponsored research agreement with Merck and Co. to develop a vaccine for chlamydia, which causes an estimated 2.3 million infections in the United States. The Merck license was the first revenue-producing license for any technology developed at UTSA.
The immunologist has published 100 research papers and has received funding from several agencies including the National Institutes of Health, the Department of Defense and the Department of Homeland Security.
Additionally, Arulanandam is one of the scientific directors of the Vaccine Development Center of San Antonio (a partnership between UTSA, the UT Health Science Center, Southwest Research Institute and Texas Biomedical Research Institute), and he directs the Center of Excellence in Infection Genomics, which is funded by the Department of Defense. The DoD center supports microbiology research, teaching and outreach activities aligned with Army priorities. He also serves as director of the South Texas Center for Emerging Infectious Diseases.
In his administrative role as assistant vice president for research support, Arulanandam is responsible for the development and implementation of strategic initiatives aimed toward growing UTSA to be a top-tier research university. Within this role, he provides leadership to the Office of Undergraduate Research, develops impactful faculty development programming and leads a team of grant development professionals focused on increasing funded research at UTSA.
Founded in 1848, the American Association for the Advancement of Science is the world's largest general scientific society and publisher of the journals Science, Translational Medicine and Science Signaling. The AAAS includes 261 affiliated societies and academies of science and serves 10 million individuals. Science has the largest paid circulation of any peer-reviewed general science journal in the world with an estimated total readership of one million.
Learn more at the South Texas Center for Emerging Infectious Diseases or Microbiology and Immunology at UTSA websites.
Community input is central to developing a well-conceived roadmap for the next 50 years of the ITC. To date, the visioning process has included opportunities for public input and ideation through two rounds of Community Conversations that sought input from a wide variety of ITC stakeholders.Virtual Event
Please join us Thursday, July 7th, 2022 for a discussion with Colonel (ret) Michael Davis, MD, FACS, FRCS (Hon), former Director of the U.S. Combat Casualty Care Research Program. Dr. Davis will discuss how to best identify strengths at UTSA that can be effectively leveraged for funding proposals to the Department of Defense.Business Building (BB `2.06.04,) Main Campus
Educators will develop strategies that can be implemented to stimulate, guide, and build capacity of diverse student populations.UTSA Downtown Campus
Participants will be introduced to applications included in Adobe Creative Cloud, a tool that is free for all UTSA faculty, staff, and students. Attendees will be able to complete short projects that will give them the opportunity to produce artifacts that they can use to improve digital literacy in their coursesVirtual Event
The Innovation Academy is an 8-hour online hybrid course designed to introduce faculty to a variety of educational ideas, best practices and resources for becoming more comfortable in teaching in different modalities. This academy will run July 18 – August 21. Upon completion of all activities, faculty will receive a one-time incentive of $1,000Virtual Event
Learn how to design surveys that are scientifically valid and are inclusive of diverse populations. Anchored in culturally and linguistically competent practices, this interactive workshop will explore and apply concepts related to the lifecycle of survey development from design to implementation.Virtual Event
The virtual conference will bring together information professionals and academics to discuss current research, ideas, insights, and best practices that advance STEM research and education.Virtual Event